MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Medtronic (NY:MDT)

96.54 -0.57 (-0.59%)
Official Closing Price Updated: 7:00 PM EDT, Oct 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Medtronic

< Previous 1 2
...
21 22 23 24 25 26 27 28 29
...
69 70 Next >
News headline image
MDT Stock Earnings: Medtronic Beats EPS, Beats Revenue for Q1 2025 ↗
MDT stock results show that Medtronic beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2025. 
Via InvestorPlace
News headline image
Medical Devices Giant Medtronic Q1 Earnings: Revenue And EPS Beat, Lifts Annual Guidance Marginally On Sustained Growth From New Product Launches ↗
Medtronic beats Q1 2025 earnings and revenue estimates with $7.9 billion in sales, driven by growth in Cardiac, Neuromodulation, and Diabetes segments. The company raises FY25 guidance, citing strong... 
Via Benzinga
News headline image
Medtronic Posts Modest Beat-And-Raise Report For Fiscal First Quarter ↗
Medtronic stock rose early Tuesday after the medtech company reported slightly better-than-expected results for its fiscal first quarter. 
Via Investor's Business Daily
News headline image
US Stocks May Take a Breather After S&P 500's Impressive 8-Session Winning Streak: Strategist Says Market Will Hit Fresh Highs In Next 4 Weeks, But Warns Investors Of Potential Risks ↗
The gravity-defying climb faces risk, as the index futures trade narrowly mixed in early trading on Tuesday. That said, the recent gains could keep traders wary of a potential pullback. 
Via Benzinga
Topics Stocks
News headline image
Key Takeaways From Medtronic Analyst Ratings ↗
 
Via Benzinga
News headline image
Looking Into Medtronic's Recent Short Interest ↗
 
Via Benzinga
News headline image
Why NYSE:MDT qualifies as a good dividend investing stock. ↗
Balancing Dividends and Fundamentals: The Case of MEDTRONIC PLC (NYSE:MDT). 
Via Chartmill
News headline image
S&P 500, Nasdaq Extend Gains For 8th Consecutive Session: Investor Sentiment Improves, But Greed Index Remains In 'Fear' Zone ↗
 
Via Benzinga
Topics Stocks
News headline image
Lowe's, Palo Alto Networks And 3 Stocks To Watch Heading Into Tuesday ↗
 
Via Benzinga
News headline image
5 Dividend Growth Stocks to Buy and Hold Forever ↗
Dividend growth stocks offer investors a powerful combination of income and capital appreciation potential, making them attractive for long-term portfolios. 
Via The Motley Fool
News headline image
3 Dividend Stocks to Double Up On Right Now ↗
How does a 5.7% dividend yield sound? 
Via The Motley Fool
News headline image
Robinhood To Rally Around 29%? Here Are 10 Top Analyst Forecasts For Thursday ↗
 
Via Benzinga
News headline image
Top Dividend Aristocrat Picks In July 2024 ↗
The following 3 dividend stocks have increased payouts for over 25 consecutive years. 
Via Talk Markets
News headline image
7 Defensive Stocks to Buy as Investors Seek Shelter ↗
With the market primed for more jitters, investors should consider battening down the hatches with these defensive stocks. 
Via InvestorPlace
News headline image
TJX To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday ↗
 
Via Benzinga
News headline image
Is PROCEPT BioRobotics the Next Big Thing in Surgical Robotics?
Surgical robotics company PROCEPT BioRobotics Co. (NASDAQ: PRCT) developed the AquaBeam Robotic System for the treatment of benign prostatic hyperplasia 
Via MarketBeat
News headline image
Abbott Laboratories Stock Could Soar to $143, According to a Wall Street Analyst. Is It a Buy Around $108? ↗
An unexpected diabetes partnership with Medtronic bodes well for Abbott's biggest growth driver. 
Via The Motley Fool
News headline image
Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update
From Orchestra BioMed Holdings, Inc.
Via GlobeNewswire
News headline image
Chips, Glorious Chips! ↗
Someone's gotta make 'em, and someone's gotta buy 'em. 
Via The Motley Fool
News headline image
Medical Technology Stock Benefits from Rising Acute Care Demand
Medical and surgical products manufacturer Stryker Co. (NYSE: SYK) is a beneficiary of the acute care boom occurring in the healthcare industry. 
Via MarketBeat
Topics Supply Chain
News headline image
Why Intuitive Surgical Stock is Dominating the Medical Sector
Robotic surgery conjures up futuristic images of automated machines performing surgery on anesthetized human patients in an assembly line. However 
Via MarketBeat
News headline image
2 Dividend Stocks to Buy and Never Sell ↗
These two are rock-solid businesses with strong dividend programs. 
Via The Motley Fool
News headline image
As Diabetes Battle Heats Up, Spotlight Turns To Dexcom, Abbott ↗
Dexcom is taking on bigger rival Abbott Laboratories with a continuous glucose monitor for non insulin users. 
Via Investor's Business Daily
News headline image
3 AI-Powered Healthcare Stocks Transforming Medicine ↗
Invest in AI healthcare stocks to benefit significantly from tech that could propel the healthcare market to $148.4 billion by 2029. 
Via InvestorPlace
Topics Artificial Intelligence
News headline image
3 AI-in-Healthcare Stocks to Buy for Outsized Returns ↗
These are the AI healthcare stocks to buy as they represent medical technology investing in research and development for accelerated growth. 
Via InvestorPlace
Topics Artificial Intelligence
News headline image
3 Blue-Chip Stocks to Buy for the Second Half of 2024 ↗
Despite recent scrutiny, blue-chip stocks offer a chance to capitalize on market lulls and a sector snapback 
Via InvestorPlace
News headline image
7 Blue-Chip Stocks to Buy on the Dip: July 2024 ↗
Buy high-quality at relative bargain prices, if you decide to take advantage of recent weakness with these seven blue-chip stocks. 
Via InvestorPlace
News headline image
Abbott Labs Makes Marketing Push For New Glucose Monitors, Targets Health-Conscious Consumers ↗
Abbott Laboratories is launching Lingo, an over-the-counter glucose monitoring device aimed at non-diabetic consumers, utilizing TV and guerilla marketing. CEO Robert Ford expects Lingo to become a... 
Via Benzinga
News headline image
If You Can Only Buy One Robotics Stock in July, It Better Be One of These 3 Names ↗
These three robotics stocks look well-positioned to ride strong secular tailwinds higher, despite most investors attention being on AI today. 
Via InvestorPlace
Topics Artificial Intelligence
News headline image
3 Dividend Stocks That Demand Investor Attention ↗
Explore and consider three heavyweight dividend stocks that offer strong yields and growth potential for savvy investors. 
Via InvestorPlace
< Previous 1 2
...
21 22 23 24 25 26 27 28 29
...
69 70 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story